Lung fibrosis (LF) is a chronic progressive, incurable, and debilitating condition of the lung,
which is associated with different lung disease. Treatment options are still sparse …

It is a challenge to keep abreast of all the clinical and scientific advances in the field of
respiratory medicine. This article contains an overview of laboratory-based science, clinical …

Abstract Idiopathic Pulmonary Fibrosis (IPF) is a debilitating and fatal lung disease
characterized by the excessive formation of scar tissue and decline of lung function. Despite …

Micro-computed tomography derived functional biomarkers used in lung disease research
can significantly complement end-stage histomorphometric measures while also allowing for …

Silicosis is a progressive pulmonary fibrosis disease caused by long-term inhalation of
silica. The early diagnosis and timely implementation of intervention measures are crucial in …

Introduction Synchrotron-based propagation-based imaging (PBI) is ideally suited for lung
imaging and has successfully been applied in a variety of in vivo small animal studies …

It is a challenge to keep abreast of all the clinical and scientific advances in the field of
respiratory medicine. This article contains an overview of laboratory-based science, clinical …

Antifibrotic therapy with nintedanib is the clinical mainstay in the treatment of progressive
fibrosing interstitial lung disease (ILD). High-dimensional medical image analysis, known as …

Background: Idiopathic pulmonary fibrosis (IPF) is a chronic progressive, incurable, and
debilitating fibrotic disease. Nintedanib–an oral tyrosine kinase inhibitor–significantly slows …